Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Auxiliary Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105111169A reveals a streamlined route for Sofosbuvir intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.
Patent CN113336726B details a novel synthesis of (R)-3-propyl-γ-butyrolactone using chiral auxiliaries, offering high purity and cost-effective manufacturing for API intermediates.
Patent CN110437216B details a cost-effective Lamivudine route using L-menthol, offering high yield and purity for pharmaceutical intermediate manufacturers.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN109438432B details a green emtricitabine synthesis using L-menthol. Offers cost reduction in antiviral API manufacturing and high-purity intermediates.
Novel method for avibactam intermediate using L-camphorsulfonamide. High yield, stereoselective route for reliable pharmaceutical intermediate supplier.
Patent CN115197115A details a novel chiral synthesis route offering high optical purity and scalable manufacturing for pharmaceutical intermediates and cost reduction.
Novel chiral auxiliary method for Tapentadol intermediates. High purity, scalable process reducing costs and lead time for pharmaceutical manufacturing supply chains.